Pillstats
Rx only · Film, Soluble · Buccal

Buprenorphine Hydrochloride

Brands: Belbuca · Buprenorphine Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US7 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN02AE01
RxCUI (US)1819
US makers1 labelers
Packages7
DEA / ScheduleCIII

US acquisition costNADAC · per unit

Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.99$7.97$11.96$15.94Dec 2025May 2026Jul 2026
$13.857
Latest avg · Jul 22, 2026
+5%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8.5K17K26K34K2025 Q12025 Q22025 Q32025 Q42026 Q1
27K
Rx · 2026 Q1
1.5M
Units dispensed
-6%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
BioDelivery Sciences International Incunknown7SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 15, 2021
    RECALLRecall (Class II): Belbuca (buprenorphine hydrochloride) buccal film 600 mcg 60 pouches containing 1 buccal film each Rx only NDC 59385-02…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC

  • Mar 15, 2021
    RECALLRecall (Class II): Belbuca (buprenorphine hydrochloride) buccal film 300 mcg 60 pouches containing 1 buccal film each Rx only NDC 59385-02…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC